BCCIP anticorps (AA 300-350)
Aperçu rapide pour BCCIP anticorps (AA 300-350) (ABIN1976967)
Antigène
Voir toutes BCCIP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 300-350
-
Specificité
- Region between residue 300 and 350 of human BRCA2 and CDKN1A interacting protein using the numbering given in entry NP_510868.1 (GeneID 56647).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IF (1:250 - 1:2000), IHC, IHC-P (1:500 - 1:2000), IP (2 - 5 μg/mg lysate)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Colon Carcinoma, Prostate Carcinoma, Testicular Seminoma.
Not recommended for: WB -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- BCCIP (BRCA2 and CDKN1A Interacting Protein (BCCIP))
-
Autre désignation
- BCCIP
-
Sujet
-
Name/Gene ID: BCCIP
Synonyms: BCCIP, BCCIPbeta, TOK-1alpha, TOK1, TOK-1, Protein TOK-1, BCCIPalpha, TOK-1beta -
ID gène
- 56647
Antigène
-